Information Library
Hear From the Experts
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Podcast: Clinical / Commercial Convergence
August 26, 2010
John Doyle, Ph.D., MPH, Vice President and Practice Leader for Market Access with the Consulting group at Quintiles, explains the concept of clinical/commercial convergence. -
Dr. Michael Shi
August 4, 2010
Dr. Michael Shi, President, United States Chinese Anti-Cancer Alliance (USCACA), Senior Director, Oncology Biomarkers, Novartis -
Podcast: Data, Patients and Payers are the Keys to New Health Success
July 13, 2010
Jay Norman, President of the Consulting group at Quintiles, talks to Outsourcing-Pharma about the constellation of stakeholders in the New Health landscape. -
Communication Strategies for Risk Minimization
July 12, 2010
In the US, the Food and Drug Administration (FDA) approves pharmaceutical products based upon the results of adequate, wellcontrolled clinical studies demonstrating that each product -
Generic Drug Approvals in the US Prior to the Hatch-Waxman Act
July 12, 2010
It is a common misconception that the Hatch-Waxman Act of 1984 created the generic drug approval process in the US. A recent article claimed there were -
The Pros and Cons of Using Virtual Data Rooms for Due Diligence
July 8, 2010
Pharmaceutical and biotech companies, strategic partnering divisions of contract research organizations (CROs) and investment firms are entering into alliances and joint ventures at an ever-increasing -
Establishing a US Sales Force Through a Strategic Alliance
July 8, 2010
In October 2007, ProStrakan Group plc, a fast-growing European-based specialty pharmaceutical company, announced its intention to establish its first US sales force through a strategic -
The Evolution of Oncologic Drug Development
July 8, 2010
Despite a doubling in the number of candidates in the cancer drug pipeline from 1990 through 2006, the overall US approval rate for cancer drugs -
FDA Requirements for Clinical Studies in Pediatric Patients
July 7, 2010
Differences in the physiology of adults and children can produce significant differences in the way they respond to drugs and vaccines. Without adequate data on pediatric -
On the Origin of the Animal Rule
July 7, 2010
New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible
